Equitas Pharmaceuticals Limited
About Equitas Pharmaceuticals Limited
Data last updated:
Equitas Pharmaceuticals Limited is a public limited company based in Nagpur, Maharashtra, India. It operates in the fine chemicals and other chemical products segment of the chemicals sector. It was incorporated on 13 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U24299MH2020PLC350156.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Girish Damodar Kalamkar and Mayuresh Dilip Katyayan.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Shree Apartment Plot No. 433 G – 1 Gorepeth Dharampeth, Nagpur, Maharashtra, India – 440010.
Company details
Contact details
Equitas Pharmaceuticals Limited's registered office is in Nagpur, Maharashtra.
- Registered AddressShree Apartment Plot No. 433 G – 1 Gorepeth Dharampeth, Nagpur, Maharashtra, India – 440010
- IndustryChemicals, Fine Chemicals And Other Chemical Products, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Equitas Pharmaceuticals Limited
FY 2023 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Equitas Pharmaceuticals Limited, buy the company report.
Board of directors of Equitas Pharmaceuticals Limited
Equitas Pharmaceuticals has 7 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Girish Damodar Kalamkar Also directs: Promarc Medicose Private Limited, Promarc Hospitals Private Limited, Promarc Pharmaceuticals Private Limited and 3 more | Director | 13 Nov 2020 | 5 Years 11 Months | Current |
| Mayuresh Dilip Katyayan Also directs: Promarc Cosmetics Private Limited, Promarc Medicose Private Limited, Promarc Software Private Limited and 5 more | Director | 13 Nov 2020 | 5 Years 11 Months | Current |
| Rahul Bhagwan Trivedi Also directs: Promarc Cosmetics Private Limited, Promarc Medicose Private Limited, Promarc Software Private Limited and 4 more | Director | 13 Nov 2020 | 5 Years 11 Months | Current |
| Yogesh Hemraj Patil Also directs: Promarc Cosmetics Private Limited, Promarc Software Private Limited, Promarc Foods Private Limited and 2 more | Director | 13 Nov 2020 | 5 Years 11 Months | Current |
| Ashutosh Shyamrao Sarve Also directs: VBKM Realinfra Ventures Private Limited | Director | 13 Nov 2020 | 5 Years 11 Months | Current |
| Mangala Fadnavs | Director | 13 Nov 2020 | 5 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Equitas Pharmaceuticals Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Equitas Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Equitas Pharmaceuticals Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Equitas Pharmaceuticals Limited has 7 board changes on record since 2020: 7 appointments. The latest: Ashutosh Shyamrao Sarve was appointed as Director on 13 Nov 2020.
Frequently asked questions
Equitas Pharmaceuticals is an active public limited company based in Nagpur, Maharashtra, India. The company works in fine chemicals and other chemical products, within the chemicals industry. It was incorporated on 13 November 2020 (6+ years old) and is registered under CIN U24299MH2020PLC350156.
Equitas Pharmaceuticals has 7 current directors:
- Girish Damodar Kalamkar - Director
- Mayuresh Dilip Katyayan - Director
- Rahul Bhagwan Trivedi - Director
- Yogesh Hemraj Patil - Director
- Ashutosh Shyamrao Sarve - Director
- Mangala Fadnavs - Director
- Saurabh Arvind Deoghare - Director
The latest financial statements of Equitas Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Equitas Pharmaceuticals is U24299MH2020PLC350156. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Equitas Pharmaceuticals was incorporated on 13 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Nagpur.
Ashutosh Shyamrao Sarve was appointed as Director on 13 Nov 2020. Girish Damodar Kalamkar was appointed as Director on 13 Nov 2020. Mangala Fadnavs was appointed as Director on 13 Nov 2020. Equitas Pharmaceuticals has 7 board changes on record in total.
The registered office of Equitas Pharmaceuticals is at Shree Apartment Plot No. 433 G – 1 Gorepeth Dharampeth, Nagpur, Maharashtra, India – 440010.
Equitas Pharmaceuticals operates in the chemicals industry, in the fine chemicals and other chemical products segment.
Equitas Pharmaceuticals can be reached at its registered office: Shree Apartment Plot No. 433 G – 1 Gorepeth Dharampeth, Nagpur, Maharashtra, India – 440010.
Equitas Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Nagpur.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
